Advance Drug-Device Compatibility & Accelerate Time to Market

Celebrating 15 years of the Injectable Device Development Summit

Enable Advanced Delivery of Complex Biologics, Optimize Patient-Centric Device Design & Accelerate Combination Product Development

*Please be aware the venue has changed. Find more information here*

The drug delivery landscape is evolving rapidly, with micro moulding driving evolving trends in self-injection devices and increasing drive towards sustainability. At the same time, sweeping regulatory shifts are reshaping the future of combination product development, as U.S. policy accelerates domestic drug approvals and heightens oversight of global manufacturing practices.

Built for device innovators by industry pioneers, the 15th Injectable Device Development Summit will unite 60+ senior leaders from pharma, biotech, and device service providers including Eli Lilly, Takeda, Sanofi, and Merck, to unpack how to enable flexible, patient-centric delivery platforms for high-viscosity, large-volume formulations. From advancing platform strategies to de-risking regulatory pathways and improving real-world usability, this is your essential forum to drive forward next-generation delivery systems that meet the needs of both regulators and patients.

View the full event guide here.

This event is FREE* to attend for drug developers to support delivery innovation and product development while connecting you with expert partners to find the right device solutions.

What’s New for 2025?

  • Overcome delivery challenges of large-volume biologics by aligning formulation, device innovation, and risk strategies to ensure safe, patient-friendly solution.
Merck Logo
  • Accelerate device submissions by leveraging platform strategies, optimizing resources, and balancing portfolio priorities for faster, scalable development.
Eli Lilly Logo
  • Improve product safety by embedding patient-centric design into risk management and device selection, ensuring delivery solutions meet real-world user needs.
Sanofi Logo
  • Streamline injectable device supply chains by selecting fully integrated partners that reduce risk, minimize delays, and support scalable, end-to-end development.
Amneal logo

Your 2025 Speaker Faculty Includes:

Companies in the Room:

abbvie logo
Biogen
Ionis Pharmaceuticals
Alexion
Bristol Myers Squibb
Kindeva
Amneal
Core Human Factors
Merck
AstraZeneca
Eli Lilly Logo
Sanofi Logo
Aviceda
Genentech
Takeda Pharmaceutical

See Why You Should Join Them:

Brochure Cover - 15th Injectable Device Development Summit 2025

2025 Partners Include:

zacros-logo-header
Stevanato group
Zwick Roell